Kennedy disease
Therapeutic area
Neurology
Rare disease
Yes
- Definition
- Kennedy's disease, also known as bulbospinal muscular atrophy (BSMA), is a rare X-linked recessive motor neuron disease characterized by proximal and bulbar muscle wasting.
- Genetic basis
- Yes
- Non-human condition
- No
- Rare disease
- Yes
- Listing at source
- Listed
- Condition name
- Kennedy disease
- Therapeutic area
- Neurology
- Kennedy disease
- Kennedy's disease
- SBMA
- SMAX1
- spinal and bulbar muscular atrophy of Kennedy, X-linked recessive
- spinal and bulbar muscular atrophy, X-linked type 1
- X-linked BSMA
- X-linked bulbospinal amyotrophy
- X-linked bulbospinal muscular atrophy
- X-linked spinal and bulbar muscular atrophy
- spinal and bulbar muscular atrophy, X-linked 1
- All therapeutic areas
- Neurology
Sources for recorded values
- Severity
- Severe
- Genetic
- Hereditary
Sources for recorded values
- MONDO ID
- MONDO:0010735
- Parent condition
- MONDO:0024237
Related records
Broader conditions (11)
- Central nervous system disorder
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Disease of genetic or genomic mechanism
- Hereditary disease
- Hereditary neurological disease
- Human disease
- Inherited neurodegenerative disorder
- Nervous system disorder
- Neurodegenerative disease
Trials (58)
- A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer
- A Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular Atrophy
- A Safety Study of JNJ-56021927 in Participants With Metastatic Castration-Resistant Prostate Cancer
- A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer
- A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer
- A Study of NIDO-361 in Patients With SBMA
- A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
- A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of AJ201 In Patients
- A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
- A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs
- Acoustic and Perceptual Markers of Dysarthria in Amyotrophic Lateral Sclerosis (ALS)
- ALS/MND Natural History Study Data Repository
- An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants
- An Open Label Prostate Cancer Study in Japanese Patients
- Androgen Deprivation Therapy in Advanced Salivary Gland Cancer
- Androgen Receptor, Implications for Health and Wellbeing: Natural History Study of Individuals With Androgen Insensitivity
- Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer
- AR, IGF-IR, IR and Peripheral Artery Disease
- Association of Polymorphisms in the Androgen Receptor Gene and Finasteride Response in Women With Androgenetic Alopecia
- Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer
Drugs in development (5)
- Clenbuterol Phase 2
- Dutasteride Phase 2
- Leuprolide acetate Phase 2
- Mexiletine hydrochloride Phase 2
- Testosterone enanthate Phase 2